T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 07/31/2016
Domestic Stock 93.1%
Foreign Stock 4.7%
Cash 1.6%
Convertibles 0.6%
Other 0.1%
Foreign Bonds 0.0%
Preferreds 0.0%
Options -0.1%
Volatility and Other Measures
as of 07/31/2016
Beta 0.85
0.34
Standard Deviation 15.96
Price/Earnings Ratio (Domestic) 18.8
Earnings Growth Rate (Domestic) 13
Turnover Rate 11.7
Median Market
Capitalization
$30,161.99 Million
Sector Diversification
as of 07/31/2016
% of Total Net Assets
Services 34.1%
Biotechnology 26.8%
Pharmaceuticals 18.6%
Products & Devices 12.1%
Life Sciences 6.7%
Miscellaneous 0.2%
10 Largest Holdings
Represents 33.91 % of Total Net Assets
View Holdings as of:
Aetna
Alexion Pharmaceuticals
Allergan
Becton, Dickinson & Company
Bristol-Myers Squibb
Cigna
Humana
McKesson
Thermo Fisher Scientific
UnitedHealth Group
As of 07/31/2016 the Health Sciences Fund had a total of 153 holdings.
See Glossary for additional details on all data elements.